Gastrointestinal Issues in Depression, Anxiety, and Neurodegenerative Diseases: A Systematic Review on Pathways and Clinical Targets Implications
CONCLUSION: Accurate diagnosis and treatment of co-existing illnesses also require coordination between psychiatrists, neurologists, gastroenterologists, and other specialties, as well as a thorough history and thorough physical examination.PMID:38500273 | DOI:10.2174/0118715273289138240306050532 (Source: CNS and Neurological Disorders Drug Targets)
Source: CNS and Neurological Disorders Drug Targets - March 19, 2024 Category: Drugs & Pharmacology Authors: Ian Richard Lucena Andriolo Bruna Longo Dayse Machado de Melo M árcia Maria de Souza Rui Daniel Prediger Luisa Mota da Silva Source Type: research

Gastrointestinal Issues in Depression, Anxiety, and Neurodegenerative Diseases: A Systematic Review on Pathways and Clinical Targets Implications
CONCLUSION: Accurate diagnosis and treatment of co-existing illnesses also require coordination between psychiatrists, neurologists, gastroenterologists, and other specialties, as well as a thorough history and thorough physical examination.PMID:38500273 | DOI:10.2174/0118715273289138240306050532 (Source: CNS and Neurological Disorders Drug Targets)
Source: CNS and Neurological Disorders Drug Targets - March 19, 2024 Category: Drugs & Pharmacology Authors: Ian Richard Lucena Andriolo Bruna Longo Dayse Machado de Melo M árcia Maria de Souza Rui Daniel Prediger Luisa Mota da Silva Source Type: research

Gastrointestinal Issues in Depression, Anxiety, and Neurodegenerative Diseases: A Systematic Review on Pathways and Clinical Targets Implications
CONCLUSION: Accurate diagnosis and treatment of co-existing illnesses also require coordination between psychiatrists, neurologists, gastroenterologists, and other specialties, as well as a thorough history and thorough physical examination.PMID:38500273 | DOI:10.2174/0118715273289138240306050532 (Source: CNS and Neurological Disorders Drug Targets)
Source: CNS and Neurological Disorders Drug Targets - March 19, 2024 Category: Drugs & Pharmacology Authors: Ian Richard Lucena Andriolo Bruna Longo Dayse Machado de Melo M árcia Maria de Souza Rui Daniel Prediger Luisa Mota da Silva Source Type: research

Gastrointestinal Issues in Depression, Anxiety, and Neurodegenerative Diseases: A Systematic Review on Pathways and Clinical Targets Implications
CONCLUSION: Accurate diagnosis and treatment of co-existing illnesses also require coordination between psychiatrists, neurologists, gastroenterologists, and other specialties, as well as a thorough history and thorough physical examination.PMID:38500273 | DOI:10.2174/0118715273289138240306050532 (Source: CNS and Neurological Disorders Drug Targets)
Source: CNS and Neurological Disorders Drug Targets - March 19, 2024 Category: Drugs & Pharmacology Authors: Ian Richard Lucena Andriolo Bruna Longo Dayse Machado de Melo M árcia Maria de Souza Rui Daniel Prediger Luisa Mota da Silva Source Type: research

Gastrointestinal Issues in Depression, Anxiety, and Neurodegenerative Diseases: A Systematic Review on Pathways and Clinical Targets Implications
CONCLUSION: Accurate diagnosis and treatment of co-existing illnesses also require coordination between psychiatrists, neurologists, gastroenterologists, and other specialties, as well as a thorough history and thorough physical examination.PMID:38500273 | DOI:10.2174/0118715273289138240306050532 (Source: CNS and Neurological Disorders Drug Targets)
Source: CNS and Neurological Disorders Drug Targets - March 19, 2024 Category: Drugs & Pharmacology Authors: Ian Richard Lucena Andriolo Bruna Longo Dayse Machado de Melo M árcia Maria de Souza Rui Daniel Prediger Luisa Mota da Silva Source Type: research

Gastrointestinal Issues in Depression, Anxiety, and Neurodegenerative Diseases: A Systematic Review on Pathways and Clinical Targets Implications
CONCLUSION: Accurate diagnosis and treatment of co-existing illnesses also require coordination between psychiatrists, neurologists, gastroenterologists, and other specialties, as well as a thorough history and thorough physical examination.PMID:38500273 | DOI:10.2174/0118715273289138240306050532 (Source: CNS and Neurological Disorders Drug Targets)
Source: CNS and Neurological Disorders Drug Targets - March 19, 2024 Category: Drugs & Pharmacology Authors: Ian Richard Lucena Andriolo Bruna Longo Dayse Machado de Melo M árcia Maria de Souza Rui Daniel Prediger Luisa Mota da Silva Source Type: research

Gastrointestinal Issues in Depression, Anxiety, and Neurodegenerative Diseases: A Systematic Review on Pathways and Clinical Targets Implications
CONCLUSION: Accurate diagnosis and treatment of co-existing illnesses also require coordination between psychiatrists, neurologists, gastroenterologists, and other specialties, as well as a thorough history and thorough physical examination.PMID:38500273 | DOI:10.2174/0118715273289138240306050532 (Source: CNS and Neurological Disorders Drug Targets)
Source: CNS and Neurological Disorders Drug Targets - March 19, 2024 Category: Drugs & Pharmacology Authors: Ian Richard Lucena Andriolo Bruna Longo Dayse Machado de Melo M árcia Maria de Souza Rui Daniel Prediger Luisa Mota da Silva Source Type: research

Emerging Treatments for Subarachnoid Hemorrhage
CNS Neurol Disord Drug Targets. 2024 Feb 22. doi: 10.2174/0118715273279212240130065713. Online ahead of print.ABSTRACTThe current landscape of therapeutic strategies for subarachnoid hemorrhage (SAH), a significant adverse neurological event commonly resulting from the rupture of intracranial aneurysms, is rapidly evolving. Through an in-depth exploration of the natural history of SAH, historical treatment approaches, and emerging management modalities, the present work aims to provide a broad overview of the shifting paradigms in SAH care. By synthesizing the historical management protocols with contemporary therapeutic a...
Source: CNS and Neurological Disorders Drug Targets - February 27, 2024 Category: Drugs & Pharmacology Authors: Matthew C Findlay Mrinmoy Kundu Jayson R Nelson Kyril L Cole Candace Winterton Samuel Tenhoeve Brandon Lucke-Wold Source Type: research

Emerging Treatments for Subarachnoid Hemorrhage
CNS Neurol Disord Drug Targets. 2024 Feb 22. doi: 10.2174/0118715273279212240130065713. Online ahead of print.ABSTRACTThe current landscape of therapeutic strategies for subarachnoid hemorrhage (SAH), a significant adverse neurological event commonly resulting from the rupture of intracranial aneurysms, is rapidly evolving. Through an in-depth exploration of the natural history of SAH, historical treatment approaches, and emerging management modalities, the present work aims to provide a broad overview of the shifting paradigms in SAH care. By synthesizing the historical management protocols with contemporary therapeutic a...
Source: CNS and Neurological Disorders Drug Targets - February 27, 2024 Category: Drugs & Pharmacology Authors: Matthew C Findlay Mrinmoy Kundu Jayson R Nelson Kyril L Cole Candace Winterton Samuel Tenhoeve Brandon Lucke-Wold Source Type: research

Emerging Treatments for Subarachnoid Hemorrhage
CNS Neurol Disord Drug Targets. 2024 Feb 22. doi: 10.2174/0118715273279212240130065713. Online ahead of print.ABSTRACTThe current landscape of therapeutic strategies for subarachnoid hemorrhage (SAH), a significant adverse neurological event commonly resulting from the rupture of intracranial aneurysms, is rapidly evolving. Through an in-depth exploration of the natural history of SAH, historical treatment approaches, and emerging management modalities, the present work aims to provide a broad overview of the shifting paradigms in SAH care. By synthesizing the historical management protocols with contemporary therapeutic a...
Source: CNS and Neurological Disorders Drug Targets - February 27, 2024 Category: Drugs & Pharmacology Authors: Matthew C Findlay Mrinmoy Kundu Jayson R Nelson Kyril L Cole Candace Winterton Samuel Tenhoeve Brandon Lucke-Wold Source Type: research

Emerging Treatments for Subarachnoid Hemorrhage
CNS Neurol Disord Drug Targets. 2024 Feb 22. doi: 10.2174/0118715273279212240130065713. Online ahead of print.ABSTRACTThe current landscape of therapeutic strategies for subarachnoid hemorrhage (SAH), a significant adverse neurological event commonly resulting from the rupture of intracranial aneurysms, is rapidly evolving. Through an in-depth exploration of the natural history of SAH, historical treatment approaches, and emerging management modalities, the present work aims to provide a broad overview of the shifting paradigms in SAH care. By synthesizing the historical management protocols with contemporary therapeutic a...
Source: CNS and Neurological Disorders Drug Targets - February 27, 2024 Category: Drugs & Pharmacology Authors: Matthew C Findlay Mrinmoy Kundu Jayson R Nelson Kyril L Cole Candace Winterton Samuel Tenhoeve Brandon Lucke-Wold Source Type: research

Emerging Treatments for Subarachnoid Hemorrhage
CNS Neurol Disord Drug Targets. 2024 Feb 22. doi: 10.2174/0118715273279212240130065713. Online ahead of print.ABSTRACTThe current landscape of therapeutic strategies for subarachnoid hemorrhage (SAH), a significant adverse neurological event commonly resulting from the rupture of intracranial aneurysms, is rapidly evolving. Through an in-depth exploration of the natural history of SAH, historical treatment approaches, and emerging management modalities, the present work aims to provide a broad overview of the shifting paradigms in SAH care. By synthesizing the historical management protocols with contemporary therapeutic a...
Source: CNS and Neurological Disorders Drug Targets - February 27, 2024 Category: Drugs & Pharmacology Authors: Matthew C Findlay Mrinmoy Kundu Jayson R Nelson Kyril L Cole Candace Winterton Samuel Tenhoeve Brandon Lucke-Wold Source Type: research

Emerging Treatments for Subarachnoid Hemorrhage
CNS Neurol Disord Drug Targets. 2024 Feb 22. doi: 10.2174/0118715273279212240130065713. Online ahead of print.ABSTRACTThe current landscape of therapeutic strategies for subarachnoid hemorrhage (SAH), a significant adverse neurological event commonly resulting from the rupture of intracranial aneurysms, is rapidly evolving. Through an in-depth exploration of the natural history of SAH, historical treatment approaches, and emerging management modalities, the present work aims to provide a broad overview of the shifting paradigms in SAH care. By synthesizing the historical management protocols with contemporary therapeutic a...
Source: CNS and Neurological Disorders Drug Targets - February 27, 2024 Category: Drugs & Pharmacology Authors: Matthew C Findlay Mrinmoy Kundu Jayson R Nelson Kyril L Cole Candace Winterton Samuel Tenhoeve Brandon Lucke-Wold Source Type: research

Emerging Treatments for Subarachnoid Hemorrhage
CNS Neurol Disord Drug Targets. 2024 Feb 22. doi: 10.2174/0118715273279212240130065713. Online ahead of print.ABSTRACTThe current landscape of therapeutic strategies for subarachnoid hemorrhage (SAH), a significant adverse neurological event commonly resulting from the rupture of intracranial aneurysms, is rapidly evolving. Through an in-depth exploration of the natural history of SAH, historical treatment approaches, and emerging management modalities, the present work aims to provide a broad overview of the shifting paradigms in SAH care. By synthesizing the historical management protocols with contemporary therapeutic a...
Source: CNS and Neurological Disorders Drug Targets - February 27, 2024 Category: Drugs & Pharmacology Authors: Matthew C Findlay Mrinmoy Kundu Jayson R Nelson Kyril L Cole Candace Winterton Samuel Tenhoeve Brandon Lucke-Wold Source Type: research

Emerging Treatments for Subarachnoid Hemorrhage
CNS Neurol Disord Drug Targets. 2024 Feb 22. doi: 10.2174/0118715273279212240130065713. Online ahead of print.ABSTRACTThe current landscape of therapeutic strategies for subarachnoid hemorrhage (SAH), a significant adverse neurological event commonly resulting from the rupture of intracranial aneurysms, is rapidly evolving. Through an in-depth exploration of the natural history of SAH, historical treatment approaches, and emerging management modalities, the present work aims to provide a broad overview of the shifting paradigms in SAH care. By synthesizing the historical management protocols with contemporary therapeutic a...
Source: CNS and Neurological Disorders Drug Targets - February 27, 2024 Category: Drugs & Pharmacology Authors: Matthew C Findlay Mrinmoy Kundu Jayson R Nelson Kyril L Cole Candace Winterton Samuel Tenhoeve Brandon Lucke-Wold Source Type: research